Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (Weighted Average) (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Shares Outstanding (Weighted Average) data on record, last reported at $26.9 million in Q2 2025.

  • For Q2 2025, Shares Outstanding (Weighted Average) rose 51.55% year-over-year to $26.9 million; the TTM value through Jun 2025 reached $26.9 million, up 51.55%, while the annual FY2024 figure was $20.8 million, 156.25% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $26.9 million in Q2 2025 per FBIO's latest filing, up from $26.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $87.6 million in Q2 2022 and bottomed at $5.9 million in Q3 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $37.1 million, with a median of $20.2 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Weighted Average): plummeted 92.75% in 2022, then skyrocketed 172.4% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $81.7 million in 2021, then tumbled by 92.75% to $5.9 million in 2022, then surged by 36.89% to $8.1 million in 2023, then soared by 156.25% to $20.8 million in 2024, then grew by 29.33% to $26.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $26.9 million in Q2 2025, $26.5 million in Q1 2025, and $20.8 million in Q4 2024.